Los nuevos anticoagulantes orales y la fibrilación auricular

Izaguirre-Ávila, Raúl; Alejandro Hernández, Pedro; Cortina-de la Rosa, Evelyn
July 2011
Archivos de Cardiología de México;jul-sep2011, Vol. 81 Issue 3, p163
Academic Journal
No abstract available.


Related Articles

  • Non-vitamin K antagonist oral anticoagulants and major bleeding-related fatality in patients with atrial fibrillation and venous thromboembolism: a systematic review and meta-analysis. Caldeira, Daniel; Rodrigues, Filipe B.; Barra, Márcio; Santos, Ana Teresa; de Abreu, Daisy; Gonçalves, Nilza; Pinto, Fausto J.; Ferreira, Joaquim J.; Costa, João // Heart;Aug2015, Vol. 101 Issue 15, p1204 

    Objective Non-vitamin K antagonist oral anticoagulants (NOACs) are efficacious and safe antithrombotic drugs but the non-availability of an antidote for potential fatal haemorrhagic events is clinically perceived as a strong limitation. We aimed at evaluating the risk of haemorrhage-related...

  • Atrial Fibrillation Treatment Update. Clem, James R. // South Dakota Medicine;Jul2011, p255 

    The article reviews the two areas of change in the atrial fibrillation treatment update which includes ventricular rate control and anticoagulation options for atrial fibrillation. The benefits of strict ventricular rate control were assessed in the Rate Control Efficacy in Permanent Atrial...

  • Antithrombotic Options for Atrial Fibrillation in 2012. Rude, Jennifer; Quevedo, Karla; Rodriguez de Armas, Lissette; Mukherjee, Debabrata // Cardiovascular & Haematological Disorders - Drug Targets;Jun2012, Vol. 12 Issue 1, p1 

    Atrial fibrillation (AF) is a common arrhythmia in clinical practice. An important component of the management of patients with AF involves prevention of thromboembolism and stroke. Coumarins, such as warfarin had been the only available oral antithrombotic agent for prevention of...

  • Left Atrial Appendage Closure: Initial Experience with the Watchman Device. Toutouzas, Konstantinos; Trantalis, George; Benetos, Georgios; Sideris, Skevos; Aggeli, Konstantina; Stefanadis, Christodoulos // Hospital Chronicles;2014, Vol. 9 Issue 2, p1 

    We herein present the first left atrial appendage (LAA) percutaneous closure procedure performed in our Institution with use of the Watchman device in an 82-year old woman with atrial fibrillation, unable to continue receiving anticoagulation therapy due to bleeding complications. A propos with...

  • Fibrilación auricular. Moreno-Ruiz, Luis Antonio; Rodríguez-Piña, Horacio; Martínez-Flores, Jerónimo Enrique // Revista Medica del IMSS;2012, Vol. 50 Issue 3, p273 

    Atrial fibrillation (AF) is the most common arrhythmia in humans. The treatment can be one of the most difficult. It's true that AF itself it's a no-lethal arrhythmia but is often a cause of symptoms that can lead the patient to worsening in his quality of life thet predispose to serious...

  • Mechanisms And Management Of Thrombo-Embolism In Atrial Fibrillation. Violi, Francesco; Pastori, Daniele; Pignatelli, Pasquale // JAFIB: Journal of Atrial Fibrillation;Oct/Nov2014, Vol. 7 Issue 3, p71 

    Atrial fibrillation (AF) is the most common cardiac arrhythmia in the general population and in patients with a history of cardiovascular disease. AF is becoming an outbreak particularly for the western countries as it increases with advancing age; furthermore, AF has a negative social impact...

  • The HAS-BLED Score Identifies Patients with Acute Venous Thromboembolism at High Risk of Major Bleeding Complications during the First Six Months of Anticoagulant Treatment. Kooiman, Judith; van Hagen, Nadja; Iglesias del Sol, Antonio; Planken, Erwin V.; Lip, Gregory Y. H.; van der Meer, Felix J. M.; Cannegieter, Suzanne C.; Klok, Frederikus A.; Huisman, Menno V. // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Objective: The HAS-BLED score enables a risk estimate of major bleeds in patients with atrial fibrillation on vitamin K-antagonists (VKA) treatment, but has not been validated for patients with venous thromboembolism (VTE). We analyzed whether the HAS-BLED score accurately identifies patients...

  • Improved persistence with non-vitamin K oral anti-coagulants compared to warfarin in patients with atrial fibrillation. Simons, L.; Freedman, B.; Ortiz, M.; Colquhoun, D. // Heart, Lung & Circulation;2015 Supplement 3, Vol. 24, pS457 

    No abstract available.

  • Comparison between CHA2DS2-VASc and the new R2CHADS2 and ATRIA scores at predicting thromboembolic event in non-anticoagulated and anticoagulated patients with non-valvular atrial fibrillation. Abumuaileq, Rami Riziq-Yousef; Abu-Assi, Emad; López-López, Andrea; Raposeiras-Roubin, Sergio; Rodríguez-Mañero, Moisés; Martínez-Sande, Luis; García-Seara, Javier; Fernandez-López, Xesús Alberte; Peña-Gil, Carlos; González-Juanatey, Jose Ramón // BMC Cardiovascular Disorders;11/19/2015, Vol. 15 Issue 1, p156 

    Background: Accurate risk stratification is considered the first and most important step in the management of patients with non-valvular atrial fibrillation (NVAF). We compared the performance of the widely used CHA2DS2-VASc and the recently developed R2CHADS2 and ATRIA scores, for...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics